|
| Wednesday, May 8, 2013 |
|
|
羅欣藥業公佈2013年第一季度業績 |
| 中國領先現代製藥企業 ─ 山東羅欣藥業股份有限公司（「羅欣藥業」或「公司」，股份編號：8058）今天宣佈截至2013年3月31日止3個月（「回顧期」）未經審核之第一季度業績。 more info >> |
|
|
Luoxin Announces 2013 First Quarterly Results |
| Shandong Luoxin Pharmacy Stock Co., Ltd. ("Luoxin" or the "Company", HKSE: 8058), a leading PRC pharmaceutical enterprise, announced its unaudited first quarterly results for the three months ended 31 March 2013 (the "period under review") today. more info >> |
|
| Wednesday, March 20, 2013 |
|
|
罗欣药业公布2012年全年业绩 |
中国领先现代制药企业─ 山东罗欣药业股份有限公司(「罗欣药业」或「公司」，股份编号：8058) 今天宣布截至2012年12月31日止年度(「回顾年度」) 经审核之全年业绩。
more info >> |
|
|
羅欣藥業公佈2012年全年業績 |
中國領先現代製藥企業 ─ 山東羅欣藥業股份有限公司(「羅欣藥業」或「公司」，股份編號：8058) 今天宣布截至2012年12月31日止年度(「回顧年度」) 經審核之全年業績。
more info >> |
|
|
Luoxin Announces 2012 Annual Results |
Shandong Luoxin Pharmacy Stock Co., Ltd. ("Luoxin" or the "Company", stock code: 8058), a leading PRC pharmaceutical enterprise, today announced its audited annual results for the year ended 31 December 2012 (the "year under review").
more info >> |
|
| Wednesday, March 24, 2010 |
|
|
羅欣藥業公佈2009 年全年業績股東應佔溢利上升46.6% |
| 中國領先現代製藥企業─ 山東羅欣藥業股份有限公司（「羅欣藥業」或「公司」，股份編號: 8058）今天宣佈截至2009年12月31日止年度（「回顧年度」）全年業績。 more info >> |
|
|
罗欣药业公布2009年全年业绩股东应占溢利上升46.6% |
| 中国领先现代制药企业 山东罗欣药业股份有限公司（「罗欣药业」或「公司」，股份编号: 8058）今天宣布截至2009年12月31日止年度（「回顾年度」）全年业绩。 more info >> |
|
|
Luoxin Pharma Announces 2009 Annual Results, Profit Attributable to Shareholders Surged 46.6% to Approximately RMB268,550,000 |
| Shandong Luoxin Pharmacy Stock Co., Ltd., one of the leading PRC pharmaceutical enterprises, announced today its annual results for the year ended 31 December 2009 ("the year under review"). more info >> |
|
| Monday, May 11, 2009 |
|
|
Luoxin Announces 2009 First Quarterly Results; Profit Attributable to Shareholders Increased 31.3% to Approximately RMB 52,727,000 |
| Shandong Luoxin Pharmacy Stock Co., Ltd. (stock code: 8058), a leading PRC pharmaceutical enterprise, announced its unaudited first quarterly results for the three months ended 31 March 2009 today, recording a steady growth in turnover and profit attributable to shareholders. more info >> |
|
|
罗欣药业公布2009年第一季度业绩,股东应占溢利攀升31.3%至约人民币5,272万元 |
| 中国制药企业─山东罗欣药业股份有限公司今天宣布截至2009年3月31日止3个月未经审核之第一季度业绩，营业额及股东应占溢利继续保持稳定增长。 more info >> |
|
|
|
|
